Baxter Launches HEMOPATCH Sealing Hemostat in New Zealand, a Room-Temperature Collagen Pad Approved for Hemostasis and Sealing

Hemostasis and Tissue Sealing Agents Market Size Worth US$ 15,396 Million by 2035 at a CAGR of 8.8% | Fact.MR

Digital ECGs at Barts Health: A high-impact win for NHS digitisation

Baxter's Novum IQ corrections grow in scope to include syringe pumps

Program Manager, Business Innovation and Optimization

Baxter is a healthcare company committed to redefining healthcare delivery and empowering individuals to make a meaningful impact. The Business Innovation and Optimization Program Manager will drive strategic transformation and operational excellence across the Enterprise Project Management Office, overseeing business systems and program initiatives to enable high-impact execution.

Sign up with Google

Sign in with Google